Pharmaceutical & Biotech Licensing Strategies - Driving Revenue through Partnerships Report Description In today’s pharmaceutical industry, multiple factors - looming patent expirations, depleted pipelines, increases in R&D expenditures, payer pressures, and tighter FDA regulations- have forced Big Pharma to change its business model. The evolving model is one grounded in collaboration. Companies are no longer relying solely on their own internal R&D programs for innovation; they are looking outside of their four walls. Some have labeled this ‘search and development’. To Get Complete Details Here @ http://www.bigmarketresearch.com/pharmaceutical-andbiotech-licensing-strategies-driving-revenue-through-partnerships-market There are many types of alliances that support this collaborative model. One type, in-licensing products, is very appealing. The number of licensing agreements has grown year over year since 2007. The top companies are interested in several key therapeutic areas including oncology, CNS, and infectious disease. These companies are also more focused on products in the early phases of development. Report Description Scope • Licensing deal trends by deal activity, therapeutic area, stage of development and value • Analysis of key players • Review of rationale behind in-licensing and out-licensing deal trends Enquire About Report@ http://www.bigmarketresearch.com/report-enquiry/132477 Please Note: This product is delivered as a zip file Report Description Key Reason To Purchase • Gain access to a fully sourced, executive assessment of the trends within pharmaceutical & biotech licensing activity and how those trends support company growth. • Identify who the leading companies are from an in-license & out-license point of view and if they are keeping to their overall corporate strategy. • Benefit from CBR’s case study analysis which supports the various motivations companies have to engage in licensing activity. • Understand the key issues driving the changes that are being seen within the pharmaceutical industry and why new business models are evolving to support continued revenue growth. Table Of Content • Executive Summary • Introduction • Licensing Deal Trends • Players in the Licensing Game • Strategic Motivations Behind Licensing Activity - A case study analysis • Appendix Table Of Content @ http://www.bigmarketresearch.com/pharmaceutical-and-biotechlicensing-strategies-driving-revenue-through-partnerships-market FOR MORE DETAILS Visit us at : http://www.bigmarketresearch.com/pharmaceutical-andbiotech-licensing-strategies-driving-revenue-throughpartnerships-market Stay With Us: TELEPHONE: +1 (855) 711-1555 E-MAIL: [email protected] 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States